“…Random indels (insertions and deletions) occur during NHEJ, leading to mutations and frameshifts in the target DNA, which lead to truncated proteins due to the premature stop codon in a different frame and prevent the translation of the active native protein. Lately, various studies have used the CRISPR/Cas9 technology to impair herpesvirus replication in vitro by targeting specific DNA sequences encoding viral proteins, such as HSV-1 [ 35 , 43 , 44 , 45 , 46 , 47 , 48 , 49 ], human alphaherpesvirus 2 (HSV-2) [ 50 , 51 , 52 ], human betaherpesvirus 5 (cytomegalovirus (CMV)) [ 35 ], human gammaherpesvirus 4 (Epstein–Barr virus (EBV) [ 35 , 53 , 54 ], and bovine alphaherpesvirus type 1 (BHV-1) [ 55 , 56 ].…”